オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/08/22 | 1,120 | 1,120 | 1,081 | 1,106 | +12 | +1.1% | 69,700 |
2016/08/19 | 1,111 | 1,136 | 1,050 | 1,094 | +22 | +2.1% | 193,100 |
2016/08/18 | 1,070 | 1,085 | 1,035 | 1,072 | +1 | +0.1% | 90,300 |
2016/08/17 | 1,101 | 1,118 | 1,070 | 1,071 | -49 | -4.4% | 90,600 |
2016/08/16 | 1,130 | 1,150 | 1,118 | 1,120 | -6 | -0.5% | 70,600 |
2016/08/15 | 1,170 | 1,214 | 1,126 | 1,126 | +13 | +1.2% | 198,700 |
2016/08/12 | 1,087 | 1,124 | 1,061 | 1,113 | +19 | +1.7% | 80,000 |
2016/08/10 | 1,040 | 1,157 | 1,040 | 1,094 | +35 | +3.3% | 258,300 |
2016/08/09 | 1,031 | 1,094 | 1,023 | 1,059 | +10 | +1% | 137,800 |
2016/08/08 | 1,100 | 1,100 | 1,047 | 1,049 | -71 | -6.3% | 214,800 |
2016/08/05 | 1,152 | 1,182 | 1,090 | 1,120 | -75 | -6.3% | 227,600 |
2016/08/04 | 1,205 | 1,234 | 1,191 | 1,195 | -25 | -2% | 161,900 |
2016/08/03 | 1,290 | 1,300 | 1,220 | 1,220 | -88 | -6.7% | 208,600 |
2016/08/02 | 1,318 | 1,339 | 1,275 | 1,308 | +18 | +1.4% | 312,600 |
2016/08/01 | 1,250 | 1,303 | 1,200 | 1,290 | +27 | +2.1% | 238,800 |
2016/07/29 | 1,262 | 1,359 | 1,190 | 1,263 | +1 | +0.1% | 656,300 |
2016/07/28 | 1,170 | 1,344 | 1,170 | 1,262 | +94 | +8% | 1,012,700 |
2016/07/27 | 1,148 | 1,168 | 1,148 | 1,168 | +23 | +2% | 80,000 |
2016/07/26 | 1,135 | 1,192 | 1,134 | 1,145 | -18 | -1.5% | 151,300 |
2016/07/25 | 1,106 | 1,212 | 1,088 | 1,163 | +27 | +2.4% | 235,600 |
2016/07/22 | 1,150 | 1,172 | 1,073 | 1,136 | +66 | +6.2% | 264,800 |
2016/07/21 | 1,100 | 1,100 | 1,052 | 1,070 | ±0 | ±0% | 106,100 |
2016/07/20 | 1,053 | 1,114 | 1,050 | 1,070 | -7 | -0.6% | 123,200 |
2016/07/19 | 1,045 | 1,098 | 1,042 | 1,077 | -23 | -2.1% | 177,600 |
2016/07/15 | 1,165 | 1,169 | 1,068 | 1,100 | -64 | -5.5% | 266,300 |
2016/07/14 | 1,162 | 1,212 | 1,160 | 1,164 | -9 | -0.8% | 146,900 |
2016/07/13 | 1,214 | 1,249 | 1,164 | 1,173 | -39 | -3.2% | 177,800 |
2016/07/12 | 1,160 | 1,220 | 1,151 | 1,212 | +60 | +5.2% | 212,300 |
2016/07/11 | 1,187 | 1,187 | 1,125 | 1,152 | +3 | +0.3% | 158,800 |
2016/07/08 | 1,189 | 1,210 | 1,120 | 1,149 | -27 | -2.3% | 240,800 |
2016/07/07 | 1,281 | 1,285 | 1,175 | 1,176 | -94 | -7.4% | 407,200 |
2016/07/06 | 1,280 | 1,342 | 1,215 | 1,270 | +18 | +1.4% | 843,500 |
2016/07/05 | 1,315 | 1,322 | 1,245 | 1,252 | -60 | -4.6% | 353,300 |
2016/07/04 | 1,325 | 1,369 | 1,303 | 1,312 | -8 | -0.6% | 453,600 |
2016/07/01 | 1,319 | 1,377 | 1,285 | 1,320 | -59 | -4.3% | 890,700 |
2016/06/30 | 1,220 | 1,490 | 1,181 | 1,379 | +181 | +15.1% | 3,743,300 |
2016/06/29 | 1,248 | 1,285 | 1,186 | 1,198 | -47 | -3.8% | 527,200 |
2016/06/28 | 1,130 | 1,295 | 1,129 | 1,245 | +125 | +11.2% | 1,364,900 |
2016/06/27 | 1,075 | 1,194 | 996 | 1,120 | +73 | +7% | 522,600 |
2016/06/24 | 1,259 | 1,265 | 911 | 1,047 | -154 | -12.8% | 896,000 |
2016/06/23 | 1,188 | 1,228 | 1,150 | 1,201 | -37 | -3% | 403,700 |
2016/06/22 | 1,333 | 1,342 | 1,205 | 1,238 | -95 | -7.1% | 414,300 |
2016/06/21 | 1,350 | 1,446 | 1,295 | 1,333 | -54 | -3.9% | 802,400 |
2016/06/20 | 1,305 | 1,436 | 1,268 | 1,387 | +124 | +9.8% | 823,400 |
2016/06/17 | 1,290 | 1,336 | 1,199 | 1,263 | +27 | +2.2% | 542,600 |
2016/06/16 | 1,400 | 1,485 | 1,181 | 1,236 | -51 | -4% | 2,115,400 |
2016/06/15 | 1,180 | 1,329 | 1,171 | 1,287 | +118 | +10.1% | 1,146,600 |
2016/06/14 | 1,427 | 1,427 | 1,169 | 1,169 | -300 | -20.4% | 1,140,400 |
2016/06/13 | 1,497 | 1,548 | 1,445 | 1,469 | -108 | -6.8% | 506,300 |
2016/06/10 | 1,591 | 1,610 | 1,490 | 1,577 | -52 | -3.2% | 1,062,500 |
2201~
2250
件表示中 / 2861件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
扶桑薬 | 220,300円 | +1.6% | -12.7% | 4.09% | 8.18倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム